Body Image Disorder in Anorexia Nervosa and Virtual Reality

Not Applicable

Terminated

• Conditions: Anorexia
• Interventions: Device: Virtual reality

• Registration Number: NCT03118921
• Lead Sponsor: University Hospital, Brest

Brief Summary

Evaluation of the tolerance and acceptability of the virtual representation of its body image.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2017-04-03
• Study First Submitted QC: 2017-04-13
• Study First Posted: 2017-04-18
• Study Start: 2017-04-20
• Primary Completion: 2019-10-31
• Study Completion: 2019-10-31
• Status Verified: 2021-12
• Last Update Submitted: 2021-12-10
• Last Update Posted: 2021-12-28

Recruitment & Eligibility

• Status: TERMINATED
• Sex: Female
• Target Recruitment: 17

Inclusion Criteria

• Women, aged between 16 and 40
• Post-puberty
• Pure restrictive anorexia nervosa, diagnosis by the DSM-V
• BMI <17.5
• Patient attending an outpatient clinic at the Bohars Psychiatric Hospital in France
• Having signed the Informed Consent Form
• For minor patients, signing the form of informed consent of both parents

Exclusion Criteria

• Associated eating disorder (bulimia, or the binge eating / purging form of anorexia nervosa),
• Psychiatric disorders (characterized depressed, anxiety disorder)
• Neurological Disorders
• Mental retardation
• Abuse or addiction to alcohol
• Abuse or dependence on psychoactive substances in the previous year.
• Patient with a protective justice measure

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Virtual reality	Virtual reality	The first session aims to present the virtual reality material that will be used. The second session will take place 2 weeks after the first session and will consist of the use of the immersion software

Primary Outcome Measures

Name	Time	Method
Self-questionnaire assessing tolerance	Day 15	Patients will have to respond to a self-administered questionnaire assessing tolerance
Self-questionnaire assessing acceptability	Day 15	Patients will have to respond to a self-administered questionnaire assessing acceptability

Secondary Outcome Measures

Name	Time	Method
Feeling of presence	Day 15	Patients will respond to a self-questionnaire of feeling of presence
Subjective experience by EDI-2 questionnaire	Day 15	Pre- and post-test comparison of body dissatisfaction by EDI-2 questionnaire.
Subjective experience by BSQ questionnaire	Day 15	Pre- and post-test comparison of body dissatisfaction by BSQ questionnaire.

Trial Locations

Locations (1)

CHRU Brest; 🇫🇷 Brest, France